UPCC 27923 Chronic Graft-versus-host Disease: clinical and biomarker outcome development

Enrolling By Invitation
99 years or below
All
Phase N/A
100 participants needed
1 Location

Brief description of study

To evaluate impact of chronic skin GVHD on quality of life. To develop and evaluate content validity of a novel patient-reported outcome measure. To identify genetic, immunologic, and other factors associated with chronic GVHD To identify unique cell types involved in cutaneous lesions of chronic GVHD. To correlate biochemical signals with clinical and patient-reported severity.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 23-0763
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator